Targeting Cancer Stem-Like Cells via Cholesterol Modulation and Ferroptosis Induction Using a Multifunctional Nanoplatform to Overcome Drug Resistance

In triple-negative breast cancer mouse models, Fe/CDP selectively targets tumors and CSCs via CD44-chondroitin sulfate interactions, enabling localized drug release.